Advertisement.

XBIT Projected Dividend Yield

XBiotech Inc ( NASDAQ : XBIT )

XBiotech Inc. is a biopharmaceutical company developing True Human monoclonal antibodies to treat diseases such as inflammatory conditions, infectious diseases, cardiovascular diseases, and cancer. These antibodies are derived from human donors with natural immune responses. The company focuses on therapies that block interleukin-1 alpha (IL-1a), which is involved in processes like tissue breakdown, angiogenesis, tumor stroma remodeling, blood clot formation, malaise, muscle wasting, and inflammation. XBiotech's products include Natrunix, a clinical-stage therapeutic for MRSA, and several pre-clinical-stage therapeutics, including an oral antibody for C. difficile colon infection.

14 YEAR PERFORMANCE RESULTS

XBIT Dividend History Detail
XBIT Dividend News
XBIT Competitors News

# of Shares: 0

Closing Price: 2.94

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2021	Jul 06, 2021	Jul 15, 2021	Jul 16, 2021	Jul 23, 2021	2.4700
2021 Total:					2.4700